KCa3.1 Inhibition of Macrophages Suppresses Inflammatory Response Leading to Endothelial Damage in a Cell Model of Kawasaki Disease

Fenglei Zheng,* Yijing Tao,* Jingjing Liu, Zhimin Geng, Ying Wang, Yujia Wang, Songling Fu, Wei Wang, Chunhong Xie, Yiying Zhang, Fangqi Gong Department of Cardiology, Children’s Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, Hangzhou,...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Zheng F, Tao Y, Liu J, Geng Z, Wang Y, Fu S, Wang W, Xie C, Zhang Y, Gong F
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2021
Materias:
Acceso en línea:https://doaj.org/article/358017947d984997ae3f51c52bd97da8
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:358017947d984997ae3f51c52bd97da8
record_format dspace
spelling oai:doaj.org-article:358017947d984997ae3f51c52bd97da82021-12-02T13:32:02ZKCa3.1 Inhibition of Macrophages Suppresses Inflammatory Response Leading to Endothelial Damage in a Cell Model of Kawasaki Disease1178-7031https://doaj.org/article/358017947d984997ae3f51c52bd97da82021-03-01T00:00:00Zhttps://www.dovepress.com/kca31-inhibition-of-macrophages-suppresses-inflammatory-response-leadi-peer-reviewed-article-JIRhttps://doaj.org/toc/1178-7031Fenglei Zheng,* Yijing Tao,* Jingjing Liu, Zhimin Geng, Ying Wang, Yujia Wang, Songling Fu, Wei Wang, Chunhong Xie, Yiying Zhang, Fangqi Gong Department of Cardiology, Children’s Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, Hangzhou, 310052, People’s Republic of China*These authors contributed equally to this workCorrespondence: Fangqi GongDepartment of Cardiology, Children’s Hospital, Zhejiang University School of Medicine; National Clinical Research Center for Child Health, No. 3333, Binsheng Road, Hangzhou, 310052, People’s Republic of ChinaTel/Fax +86-571-86670008Email gongfangqi@zju.edu.cnPurpose: Macrophages-mediated inflammation is linked with endothelial damage of Kawasaki disease (KD). KCa3.1, a calcium-activated potassium channel, modulates inflammation of macrophages. However, little is known about the role of KCa3.1 in inflammation by macrophages involved in KD. Hence, this study is aimed to explore the potential role of KCa3.1 in regulating inflammatory response by macrophages and subsequent vascular injury in an in vitro model of KD.Methods: RAW264.7 cells were stimulated with Lactobacillus casei cell wall extract (LCWE) with or without TRAM-34 or PDTC or AG490. Subsequently, mouse coronary artery endothelial cells (MCAECs) were incubated with RAW264.7 cells-conditioned medium to mimic local inflammatory lesions in KD. CCKi8 assay was used to evaluate cell viability. The mRNA levels of inflammatory mediators were detected by qRT-PCR. Expressions of KCa3.1, MCAECs injury-associated molecules, proteins involved in signal pathways of nuclear factor-κB (NF-κB), signal transducers and activators of transcription (STAT) 3 and p38 were evaluated by Western blot.Results: Our study showed that LCWE increased KCa3.1 protein level in RAW264.7 macrophages and KCa3.1 inhibition by TRAM-34 notably suppressed the expression of pro-inflammatory molecules in LCWE-treated macrophages via blocking the activation of NF-κB and STAT3 pathways. Besides, the inflammation and damage of MCAECs were attenuated in the TRAM-34-treated group compared with the KD model group. This vascular protective role was dependent on the down-regulation of NF-κB and STAT3 signal pathways, which was confirmed by using inhibitors of NF-κB and STAT3.Conclusion: This study demonstrates that KCa3.1 blockade of macrophages suppresses inflammatory reaction leading to mouse coronary artery endothelial cell injury in a cell model of KD by hampering the activation of NF-κB and STAT3 signaling pathway. These findings imply that KCa3.1 may be a potential therapeutic target for KD.Keywords: Kawasaki disease, macrophages, inflammation, KCa3.1, vascular damageZheng FTao YLiu JGeng ZWang YWang YFu SWang WXie CZhang YGong FDove Medical Pressarticlekawasaki diseasemacrophagesinflammationkca3.1vascular damagePathologyRB1-214Therapeutics. PharmacologyRM1-950ENJournal of Inflammation Research, Vol Volume 14, Pp 719-735 (2021)
institution DOAJ
collection DOAJ
language EN
topic kawasaki disease
macrophages
inflammation
kca3.1
vascular damage
Pathology
RB1-214
Therapeutics. Pharmacology
RM1-950
spellingShingle kawasaki disease
macrophages
inflammation
kca3.1
vascular damage
Pathology
RB1-214
Therapeutics. Pharmacology
RM1-950
Zheng F
Tao Y
Liu J
Geng Z
Wang Y
Wang Y
Fu S
Wang W
Xie C
Zhang Y
Gong F
KCa3.1 Inhibition of Macrophages Suppresses Inflammatory Response Leading to Endothelial Damage in a Cell Model of Kawasaki Disease
description Fenglei Zheng,* Yijing Tao,* Jingjing Liu, Zhimin Geng, Ying Wang, Yujia Wang, Songling Fu, Wei Wang, Chunhong Xie, Yiying Zhang, Fangqi Gong Department of Cardiology, Children’s Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, Hangzhou, 310052, People’s Republic of China*These authors contributed equally to this workCorrespondence: Fangqi GongDepartment of Cardiology, Children’s Hospital, Zhejiang University School of Medicine; National Clinical Research Center for Child Health, No. 3333, Binsheng Road, Hangzhou, 310052, People’s Republic of ChinaTel/Fax +86-571-86670008Email gongfangqi@zju.edu.cnPurpose: Macrophages-mediated inflammation is linked with endothelial damage of Kawasaki disease (KD). KCa3.1, a calcium-activated potassium channel, modulates inflammation of macrophages. However, little is known about the role of KCa3.1 in inflammation by macrophages involved in KD. Hence, this study is aimed to explore the potential role of KCa3.1 in regulating inflammatory response by macrophages and subsequent vascular injury in an in vitro model of KD.Methods: RAW264.7 cells were stimulated with Lactobacillus casei cell wall extract (LCWE) with or without TRAM-34 or PDTC or AG490. Subsequently, mouse coronary artery endothelial cells (MCAECs) were incubated with RAW264.7 cells-conditioned medium to mimic local inflammatory lesions in KD. CCKi8 assay was used to evaluate cell viability. The mRNA levels of inflammatory mediators were detected by qRT-PCR. Expressions of KCa3.1, MCAECs injury-associated molecules, proteins involved in signal pathways of nuclear factor-κB (NF-κB), signal transducers and activators of transcription (STAT) 3 and p38 were evaluated by Western blot.Results: Our study showed that LCWE increased KCa3.1 protein level in RAW264.7 macrophages and KCa3.1 inhibition by TRAM-34 notably suppressed the expression of pro-inflammatory molecules in LCWE-treated macrophages via blocking the activation of NF-κB and STAT3 pathways. Besides, the inflammation and damage of MCAECs were attenuated in the TRAM-34-treated group compared with the KD model group. This vascular protective role was dependent on the down-regulation of NF-κB and STAT3 signal pathways, which was confirmed by using inhibitors of NF-κB and STAT3.Conclusion: This study demonstrates that KCa3.1 blockade of macrophages suppresses inflammatory reaction leading to mouse coronary artery endothelial cell injury in a cell model of KD by hampering the activation of NF-κB and STAT3 signaling pathway. These findings imply that KCa3.1 may be a potential therapeutic target for KD.Keywords: Kawasaki disease, macrophages, inflammation, KCa3.1, vascular damage
format article
author Zheng F
Tao Y
Liu J
Geng Z
Wang Y
Wang Y
Fu S
Wang W
Xie C
Zhang Y
Gong F
author_facet Zheng F
Tao Y
Liu J
Geng Z
Wang Y
Wang Y
Fu S
Wang W
Xie C
Zhang Y
Gong F
author_sort Zheng F
title KCa3.1 Inhibition of Macrophages Suppresses Inflammatory Response Leading to Endothelial Damage in a Cell Model of Kawasaki Disease
title_short KCa3.1 Inhibition of Macrophages Suppresses Inflammatory Response Leading to Endothelial Damage in a Cell Model of Kawasaki Disease
title_full KCa3.1 Inhibition of Macrophages Suppresses Inflammatory Response Leading to Endothelial Damage in a Cell Model of Kawasaki Disease
title_fullStr KCa3.1 Inhibition of Macrophages Suppresses Inflammatory Response Leading to Endothelial Damage in a Cell Model of Kawasaki Disease
title_full_unstemmed KCa3.1 Inhibition of Macrophages Suppresses Inflammatory Response Leading to Endothelial Damage in a Cell Model of Kawasaki Disease
title_sort kca3.1 inhibition of macrophages suppresses inflammatory response leading to endothelial damage in a cell model of kawasaki disease
publisher Dove Medical Press
publishDate 2021
url https://doaj.org/article/358017947d984997ae3f51c52bd97da8
work_keys_str_mv AT zhengf kca31inhibitionofmacrophagessuppressesinflammatoryresponseleadingtoendothelialdamageinacellmodelofkawasakidisease
AT taoy kca31inhibitionofmacrophagessuppressesinflammatoryresponseleadingtoendothelialdamageinacellmodelofkawasakidisease
AT liuj kca31inhibitionofmacrophagessuppressesinflammatoryresponseleadingtoendothelialdamageinacellmodelofkawasakidisease
AT gengz kca31inhibitionofmacrophagessuppressesinflammatoryresponseleadingtoendothelialdamageinacellmodelofkawasakidisease
AT wangy kca31inhibitionofmacrophagessuppressesinflammatoryresponseleadingtoendothelialdamageinacellmodelofkawasakidisease
AT wangy kca31inhibitionofmacrophagessuppressesinflammatoryresponseleadingtoendothelialdamageinacellmodelofkawasakidisease
AT fus kca31inhibitionofmacrophagessuppressesinflammatoryresponseleadingtoendothelialdamageinacellmodelofkawasakidisease
AT wangw kca31inhibitionofmacrophagessuppressesinflammatoryresponseleadingtoendothelialdamageinacellmodelofkawasakidisease
AT xiec kca31inhibitionofmacrophagessuppressesinflammatoryresponseleadingtoendothelialdamageinacellmodelofkawasakidisease
AT zhangy kca31inhibitionofmacrophagessuppressesinflammatoryresponseleadingtoendothelialdamageinacellmodelofkawasakidisease
AT gongf kca31inhibitionofmacrophagessuppressesinflammatoryresponseleadingtoendothelialdamageinacellmodelofkawasakidisease
_version_ 1718392846292090880